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ABSTRACT  
Objectives: Interventions to reduce hospital-acquired bloodstream infection (BSI) have 
succeeded in reducing rates in US paediatric intensive care units (PICUs) but there is a lack 
of evidence for the impact of similar interventions in the UK. We assessed variation in BSI 
rates within and between PICUs over a 10-year period, during which time infection control 
strategies (care bundles) were implemented. 
Design: Observational study linking laboratory data to national audit data of paediatric 
intensive care admissions (PICANet). 
Setting: 20 PICUs in England and Wales, 2003-2012. 
Patients: 102,999 children <16 years. 
Interventions: Implementation of infection control strategies in PICU captured through a 
survey of clinicians. 
Measurements and main results: Rates of BSI per 1000 bed-days were estimated from 
samples taken between 2 days after admission and up to 2 days following discharge from 
PICU. 2.0% of children experienced at least one BSI, corresponding to 5.11 (95% CI 4.90-
5.31) per 1000 bed-days. There was a significant difference in trends pre-implementation of 
infection control strategies (annual decrease of 8.0%; 95% CI 6.3%-9.7%) versus post-
implementation (annual decrease of 13.4%; 95% CI 10.3%-16.4%). By 24 months post-
implementation, the rate of BSI fell 25.5% since the reported implementation date and was 
15.1% lower than would have been expected if pre-implementation trends had continued.  
Conclusions: Our population-based study of PICUs in England and Wales demonstrates a 
steady decline in BSI rates over time. In addition, there was a significant and incremental 
further decrease in rates associated with timing of implementation of infection control 
strategies. Assessment of BSI trends before as well as after implementation of infection 
control strategies can be facilitated using data linkage and is important to avoid over-
estimating the impact of unit level interventions to improve infection control. Advances in 
collection and linkage of real-time data could further support quality improvement efforts.  
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Introduction 
Bloodstream infection (BSI) is an important cause of adverse clinical outcome and cost to 
the UK National Health Service (NHS). Paediatric intensive care units (PICUs) have one of the 
highest reported rates of hospital-acquired BSI of any clinical specialty.(1-4) An estimated 
70% of BSI in PICU is caused by central venous catheters (CVCs), an important focus for a 
number of quality improvement initiatives.(5-7) Interventions have succeeded in 
dramatically decreasing BSI rates in the US, with reported reductions of up to 66% in rates 
of catheter-related BSI 18 months post-implementation.(8, 9) Following a Comprehensive 
Spending Review in 2007 in the UK, the Department of Health invested £270 million a year 
to support infection prevention and control, including the updated Saving Lives CVC care 
bundle.(7, 10) However, there is a lack of evidence on the impact of these strategies, with 
monitoring mostly limited to process measures that were collated only locally.  
The use of administrative healthcare data is being increasingly recognised as an efficient 
approach for monitoring quality of care.(11) In the UK, no single dataset captures both the 
clinical data on length of stay and microbiological BSI data required to derive risk-adjusted 
BSI rates.(12) However, linkage of data between  the national  laboratory surveillance 
database (LabBase2; coordinated by Public Health England) and clinical information from 
the Paediatric Intensive Care Audit Network (PICANet) provides the opportunity to estimate 
risk-adjusted BSI trends and efficiently monitor quality of care in PICUs in England and 
Wales.(13-15) We used these data to derive national trends in BSI in PICU over a ten-year 
period and to compare trends before and after the reported implementation of infection 
control strategies. Our study is the first to combine national data on BSI trends with 
reported changes in PICU practice.   
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Materials and methods 
Although infection control strategies focussed on CVC-related BSI, we estimated rates of BSI 
from any source. This is justified by the importance of monitoring BSI whether a child has a 
CVC or not, and the hypothesis that infection control strategies may have broader 
implications (e.g. for hand hygiene or skin preparation). 
To distinguish PICU from high dependency care, we restricted analyses to PICUs with more 
than 200 admissions per year on average (22/25 PICUs in England and Wales). We further 
excluded two PICUs due to a lack of reporting to LabBase2. The remaining 20 PICUs 
comprised 102,999/141,164=73% of total admissions to PICUs between 2003 and 2012. 
Survey data  
We surveyed all 22 PICUs by post or email between April and Sept 2012. A designated nurse 
and consultant were asked to complete a questionnaire relating to infection control 
practices designed to reduce CVC-related BSI in PICU and to give approximate dates for 
implementation of these strategies, which were based mainly on Saving Lives or Matching 
Michigan initiatives.(5, 7) Strategies relating to Saving Lives focussed on CVC insertion 
(guidelines for catheter type, insertion site, skin preparation, hand hygiene, aseptic 
technique, dressings etc.) or maintenance (guidelines for catheter site inspection, injection 
ports, catheter access, replacement of CVCs and administrative sets etc.).(7) Strategies 
relating to Matching Michigan (a two-year quality improvement project funded by the 
Department of Health; including 21 PICUs 2009-2010) aimed to improve guidance and 
training in insertion and maintenance of CVCs and to monitor BSI rates through a staff-
reported daily census for each unit.(5)  
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PICU data 
Data on all clinically relevant PICU admission characteristics for children aged <16 years 
from March 2003 to December 2012 were extracted from the PICANet database (t, Table 
1).(13)  
Microbiology data  
All positive isolates from blood culture captured by the national laboratory surveillance 
system for children aged <16 years between 2003 and 2012 were extracted from LabBase2. 
(11, 15, 16) We have previously validated LabBase2 against reference data obtained directly 
from laboratories, and taking into account reporting gaps (e.g. through failure to upload), 
we estimated that LabBase2 ascertains 80-95% of clinically significant BSI in children.(17) 
Reporting gaps were due to system or staffing issues at the laboratory level and 
ascertainment was unrelated to individual patient or PICU-level factors such as the type of 
organism, time period or the number of reports. This means that valid comparison of trends 
between PICUs was still possible.(14)  
Data linkage 
A detailed description of the linkage between PICANet and LabBase2 has been published 
elsewhere.(14) Briefly, a combination of linkage methods was used to identify PICANet 
admission records that had a corresponding record of BSI in LabBase2, based on agreement 
between NHS number, Hospital number, first name, surname, date of birth, postcode, sex 
and location (laboratory and hospital). We evaluated the linkage against reference data and 
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demonstrated that linkage errors resulted in a small amount of bias (rates were 
underestimated by 0.5%).(14)  
Case definition  
We defined an episode of BSI as any positive blood culture with one or more organisms 
isolated from any blood sample taken on the same day. Repeated samples of the same 
organism within 14 days were treated as the same episode; two or more different 
organisms isolated on different days were treated as separate episodes. For children who 
already had BSI on admission, we excluded samples that were the same organism as that 
isolated before admission.  
For this study, we were interested in BSI occurring during a PICU admission (PICU-acquired 
BSI). We therefore excluded samples taken on the day of admission to PICU or the day after 
admission. We included samples taken up to two days following discharge from PICU.  
Analysis 
The rate of BSI was defined as the number of BSI per 1000 bed-days. Multi-level Poisson 
regression was used to model the rate of BSI over time, allowing for clustering of admissions 
within PICUs (see supplementary Appendix 1). Backwards stepwise regression (p<0.05) was 
used to identify significant risk-factors based on admission characteristics in Table 1 (age in 
months and quarter-year of admission were treated as continuous variables within the 
model, all other variables were categorical). Model fit and non-linear relationships for age 
and time at risk were assessed using likelihood ratio tests, Akaike’s Information Criterion, 
Bayesian Information Criterion, and diagnostic plots of residuals. Appropriateness of the 
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Poisson model was verified using a goodness-of-fit test based on the deviance statistic. 
Smoothed rates were plotted on the log-scale (with 0.5 added to observations where 
observed rate=0). Incidence-rate ratios were used to compare rates according to different 
risk-factors. Analysis was performed using Stata 12.(18)  
To examine differences in trends in periods before and after implementation of infection 
control strategies, a variable representing time was created, centred on implementation 
according to the survey responses. Where dates were different for insertion and 
maintenance bundles, the earliest date was used. For units where a year but no month was 
provided, mid-year was used in analysis. Analysis was restricted to PICUs where at least one 
implementation date had been provided. An interaction term between time and use of 
strategy was fitted in the model to test for differences in trends pre- and post-
implementation. The expected trend, had there been no implementation of infection 
control strategies, was produced from model predictions. This trend was extrapolated for 24 
months post-implementation, to derive the expected rate had there been no intervention. 
The expected trend was then compared with the observed trend 24-months post-
implementation. 
For the most recent period (2011-2012), by which time infection control strategies had been 
implemented, a funnel plot was used to examine the variation among PICUs in risk-adjusted 
rates.(19) To account for different patient populations at different PICUs, risk-adjusted rates 
for each PICU were produced by dividing the PICU’s unadjusted rate by its predicted rate, 
and multiplying this ratio by the average rate across all PICUs.(19) This plot indicated 
whether the rate in an individual PICU differed significantly from the national rate.   
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Results  
Rates of BSI  
Between March 2003 and December 2012, there were 102,999 admissions to the 20 study 
PICUs, corresponding to a total of 479,641 bed-days. For these admissions, there were 2452 
episodes of BSI, and 2045 admissions (2.0%) experienced at least one BSI (Table 1). The 
overall rate of BSI was 5.11 (95% CI 4.90-5.31) per 1000 bed-days. Quarter-year of 
admission, age, vasoactive agent, renal support, primary diagnosis group on admission and 
ventilation status ( invasive only, non-invasive only,  both or neither) were independently 
significantly associated with BSI (Table 2). 
Trends in BSI 
Risk-adjusted rates of BSI (controlling for independent risk-factors for BSI in Table 2) 
decreased across all 20 PICUs by an annual average of 13.2% (95% CI 11.8-14.6%). Risk-
adjusted rates fell from 8.96 (95% CI 7.72-10.20) per 1000 bed-days in 2003 to 2.87 (95% CI 
2.40-3.35) in 2012. This corresponded to an absolute rate reduction of 68% over the ten 
year period. Rates were falling at a faster rate in admissions diagnosed with infection 
compared with other diagnoses and by the end of the study period, rates in children 
admitted with a primary diagnosis of infection were similar to those for children admitted 
for cardiovascular problems (Figure 1). Adjusted trends in BSI differed between PICUs 
(Figure 2).  
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Survey data  
Fourteen PICUs provided survey responses on the implementation of infection control 
strategies (Table 3). For these PICUs, there was a significant difference in trends pre- and 
post-implementation for all admissions: adjusted rates were decreasing by 8.0% (95% CI 6.3-
9.7%) per year pre-implementation and decreasing by 13.4% (95% CI 10.3-16.4) per year 
post-implementation. The observed rate of BSI fell 25.5% from 4.47 (95% CI 2.52-6.42) per 
1000 bed-days at the time of implementation to 3.33 (95% CI 1.34-5.32) 24 months post-
implementation (based on 12/14 PICUs with data at 24 months post-implementation, see 
Figure 3). Assuming pre-implementation trends had continued at the same rate, the 
expected rate for 24 months post-implementation was 3.92 (95% CI 1.76-6.08), 
corresponding to an absolute rate reduction of 15.1%. 
Variation between PICUs 
Data for the most recent years (2011-2012) was available for 18 PICUs. Figure 4 shows 
significant variation in the risk-adjusted rate of BSI between PICUs in this period (confidence 
intervals for PICUs with highest and lowest rates do not overlap). However, variation was 
not attributed to one particular outlying PICU. The funnel plot shows that the majority of 
PICUs fell within the expected range of the national rate (Figure 4).  
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Discussion  
Our population-based study of PICUs in England and Wales quantifies a steady decline in BSI 
rates over time. Use of longitudinal administrative data allowed us to identify that rates 
were decreasing in all main clinical groups long before implementation of specific infection 
control strategies. However, we demonstrate that there was a significant and incremental 
further decrease in rates associated with the timing of implementation of infection control 
strategies, over and above background trends. We estimated that 24 months after 
implementation, BSI rates for all children in PICU had fallen by 26% and were 15% lower 
than they would have been had pre-implementation trends continued. Decreases in rates 
were not restricted to children with CVCs, and this may have been achieved through 
improvements in infection control more generally (such as hand hygiene).(7) Our study 
demonstrates that linkage of administrative data can be used for long-term continuous 
monitoring of a broad range of outcomes and is important for capturing trends before as 
well as after infection control initiatives to avoid wrongly attributed interventional 
effects.(5)  
Like previous studies evaluating implementation of infection control strategies or care 
bundles, our study was an observational analysis with trends potentially affected by factors 
other than reported practice.(5) This is demonstrated by the 8% annual decline in BSI rates 
pre-implementation of infection control strategies in our study. The decrease in rates of BSI 
(26%) in 24 months following the introduction of infection control strategies was a smaller 
reduction than seen in other studies reporting the impact of interventions in US adult ICUs 
(reduction of up to 66%) and in two  UK studies (reported reductions of 50-75%).(11, 20, 21) 
The small effect in our study may have been due in part to uncertainty around 
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implementation dates as recorded in clinician survey responses, which may have resulted in 
an underestimated impact due to recall bias. Strategies in place prior to the implementation 
dates used in our analysis may have contributed to the observed effect.(22) Alternatively, 
other studies may not have fully taken into account declining background trends for all 
patients. We were unable to directly compare results with other studies as we could not 
derive rates per CVC-days.  
This study was only possible through the linkage of national data on PICU admissions and 
infection surveillance, which offered an efficient and cost-effective method for exploiting 
existing data with comprehensive coverage over an extended study period. Linkage 
between PICANet and LabBase2 provides a rich but imperfect dataset allowing enhanced 
monitoring of BSI in PICU. Our study was limited in that the surveillance data did not provide 
a validated diagnosis of BSI in PICU and may have included BSI that should be considered as 
contaminants. We were also unable to investigate changes in sampling frequency over time, 
or to directly identify children who required a CVC. Data quality in administrative data can 
be an issue but, as in this case, may not necessarily be conditioned on the exposure or 
outcomes of interest. While monitoring schemes for specific implementation studies can 
pre-specify the data to be collected, they are costly, do not capture data pre-intervention, 
and can be dependent on clinician judgement of outcomes.(23) In contrast, administrative 
data provides the opportunity to analyse routinely-recorded data for entire units and to 
take into account background trends before and during implementation of interventions.  
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Conclusion 
Linkage of national administrative data sources provides an opportunity to monitor quality 
of care through enhanced surveillance of BSI trends in PICU. In the UK PICUs, rates of BSI 
were already falling before the implementation of infection control strategies, but these 
interventions were associated with a significant additional reduction in BSI. Standardised 
recording of unit-level interventions could help to increase understanding of variations in 
practice, and to identify interventions that lead to improvements in outcomes. The 
combination of improved characterisation of unit practices and monitoring of BSI using 
linked administrative data would allow PICUs most likely to benefit from improved practices 
to learn from others. Monitoring quality of care by measuring variation in BSI outcomes in 
PICU could then help to sustain improvements in practice.(24, 25)  
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Table 1: Characteristics of admissions to paediatric intensive care units (PICUs) in England and Wales 2003-
2012. BSI = bloodstream infection; HDU = high dependency unit; A&E = accident and emergency; NICU = 
neonatal intensive care unit; PIM2 = paediatric index of mortality score (version 2).  
  
Admissions with no BSI 
(n=100,954) 
Admissions with BSI 
(n=2,045) 
  n % n % 
Sex 
Male 57,205 56.7 1,186 58.0 
Female 43,686 43.3 859 42.0 
Unknown 63 0.1 0 0.0 
Age  
<1 month  15,395 15.2 443 21.7 
1 - <12 months 31,075 30.8 828 40.5 
1 – 4 years  26,745 26.5 455 22.3 
5 – 10 years 14,135 14.0 183 9.0 
11 – 15 years 13,604 13.5 136 6.7 
Unknown 1 0.0 0 0.0 
Length of stay in 
hours 
1-<4 3,336 3.3 5 0.2 
4-<12 7,307 7.2 15 0.7 
12-<24 19,751 19.6 52 2.6 
24-<48 21,722 21.5 80 3.9 
48+ 48,838 48.4 1,893 92.6 
Vasoactive agent Yes 29,254 29.0 1,192 58.3 
Renal support Yes 3,184 3.2 336 16.4 
Retrieval  Yes 34,525 34.2 868 42.4 
Retrieval team 
Non-specialist team 1,889 5.5 29 3.3 
Other specialist team  12,126 35.1 309 35.6 
Own team 20,061 58.1 515 59.3 
Unknown 449 1.3 15 1.7 
Care area of 
admission 
A&E 17,326 17.2 238 11.6 
HDU (step-up/step-down unit) 4,082 4.0 104 5.1 
ICU / PICU / NICU 10,983 10.9 389 19.0 
Other intermediate care area 1,748 1.7 52 2.5 
Recovery only 629 0.6 12 0.6 
Theatre and recovery 38,353 38.0 603 29.5 
X-ray / endoscopy / CT scanner 746 0.7 10 0.5 
Ward 23,135 22.9 571 27.9 
Unknown 3,952 3.9 66 3.2 
Ventilation 
status 
Neither 31,497 31.2 253 12.4 
Non-invasive only 4,902 4.9 32 1.6 
Invasive only 52,162 51.7 1,118 54.7 
Both 11,022 10.9 597 29.2 
Unknown 1,371 1.4 45 2.2 
Admission type 
Planned 39,216 38.8 683 33.4 
Unplanned 61,511 60.9 1,357 66.4 
Unknown 227 0.2 5 0.2 
Admission 
source 
Same hospital 62,252 61.7 1,104 54.0 
Other hospital 37,515 37.2 936 45.8 
Unknown 1,187 1.2 5 0.2 
PIM2 
<1% 29,518 29.2 237 11.6 
1-5% 44,432 44.0 810 39.6 
5-15% 19,663 19.5 626 30.6 
15-30% 4,250 4.2 229 11.2 
30%+ 3,091 3.1 143 7.0 
Primary 
diagnosis group 
on admission 
Cardiology 28,313 28.0 733 35.8 
Respiratory 27,569 27.3 451 22.0 
Infection 5,482 5.4 265 12.9 
18 
Other 39,590 39.2 596 29.1 
Unit type 
General 38,727 38.4 607 29.7 
Mixed 58,729 58.2 1,330 65.0 
Cardiac 3,498 3.5 108 5.3 
Unit size 
0-650 32,564 32.3 463 22.6 
650-1000 46,291 45.9 1,017 49.7 
>1000 22,099 21.9 565 27.6 
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Table 2: Independent risk-factors for bloodstream infection based on multi-level Poisson model. Quarter-
year of admission is a continuous variable for 3-monthly periods from January-March 2003 to October-
December 2012.*p-value<0.05; ** p-value<0.001 
  Incidence-rate ratio 95% confidence interval 
Age (in months)         0.996** 0.996-0.997 
Vasoactive agent       1.61** 1.45-1.79 
Renal support       1.46** 1.31-1.63 
Quarter-year of admission      0.97** 0.96-0.97 
Ventilation status 
Neither 1.00                          
Non-invasive only   0.67* 0.46-0.96 
Invasive only 1.03 0.88-1.21 
Both 1.13 0.96-1.34 
Primary diagnosis 
group on admission 
Other 1.00  
Cardiology 0.90 0.80-1.01 
Respiratory      0.58** 0.52-0.66 
Infection     1.72** 1.49-1.98 
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Table 3: Survey responses to questions relating to infection control strategies for central venous catheter 
(CVC) care, from the 20 paediatric intensive care units (PICUs) analysed. 
 
 
Insertion Maintenance 
PICU 
Do you use a 
care bundle for 
Insertion of 
CVCs? 
If yes, please give an 
approximate month and 
year for when the care 
bundle was  first 
implemented 
Do you use a care 
bundle for the 
Ongoing Care of 
CVCs? 
If yes, please give an 
approximate month and 
year for when the care 
bundle was  first 
implemented 
1 Yes 2011 Don't know  
2 Yes January 2008 Yes January 2008 
3 Yes August 2007 Yes August 2004 
4 Yes 2010 Yes 2007 
5 Yes Currently being revised Yes  
6 Yes January 2009 No  
7 Yes November 2009 Yes  
8 No  Yes June 2007 
9 Yes March 2011 Yes March 2011 
10 Yes May 2010 Yes May 2010 
11 Did not return survey 
12 Did not return survey 
13 Yes 2010 Yes 2010 
14 Yes September 2009 Yes September 2009 
15 Yes January 2010 Yes July 2010 
16 Yes January 2010 Yes January 2010 
17 No  Yes   
18 Did not return survey 
19 Yes May 2009 No  
20 No  No  
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Figure 1: Trends in rates of bloodstream infection (BSI) per 1000 bed-days by primary 
diagnosis group at admission. Averaging across all admission groups, rates decreased by 
13% per year. Symbols=observed rates for each diagnosis group; lines=smoothed adjusted 
rates.  
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Figure 2: Varying trends in rates of bloodstream infection (BSI) per 1000 bed-days by PICU of 
admission. Vertical lines show implementation dates of infection control strategies for CVC 
insertion and maintenance according to survey responses. Symbols=model rates; 
lines=smoothed model rates.  
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Figure 3: Trends in rates of bloodstream infection (BSI) per 1000 bed-days for pre- and post-
implementation of infection control strategies in 12 PICUs. Data are centred at date of 
implementation (0 months since bundle implementation). By 24-months post-
implementation, rates were 15% lower than would have been expected if pre-
implementation rates had continued with the same trend. Symbols = observed rates by 30-
days; solid lines = smoothed adjusted rates; dashed line = predicted rate if trend in pre-
implementation period had continued.  
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Figure 4: Caterpillar and funnel plot showing risk-adjusted rates of BSI in 18 PICUs in England 
and Wales 2011-2012. PICUs 10 and 20 were excluded due to a lack of data in these years.  
Confidence intervals for PICUs with highest and lowest rates in the caterpillar plot do not 
overlap, showing shows significant variation in risk-adjusted rates of BSI between PICUs. The 
majority of PICUs fall within the 95% funnel plot limits, showing that most PICUs were had 
rates within an expected distance from the national average. 
 
